Attenuated liver fibrosis in the absence of B cells
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Analysis of mononuclear cells in the adult mouse liver revealed that B cells represent as much as half of the intrahepatic lymphocyte population. Intrahepatic B cells (IHB cells) are phenotypically similar to splenic B2 cells but express lower levels of CD23 and CD21 and higher levels of CD5. IHB cells proliferate as well as splenic B cells in response to anti-IgM and LPS stimulation in vitro. VDJ gene rearrangements in IHB cells contain insertions of N,P region nucleotides characteristic of B cells maturing in the adult bone marrow rather than in the fetal liver. To evaluate whether B cells can have an impact on liver pathology, we compared CCl4-induced fibrosis development in B cell-deficient and wild-type mice. CCl4 caused similar acute liver injury in mutant and wild-type mice. However, following 6 weeks of CCl4 treatment, histochemical analyses showed markedly reduced collagen deposition in B cell-deficient as compared with wild-type mice. By analyzing mice that have normal numbers of B cells but lack either T cells or immunoglobulin in the serum, we established that B cells have an impact on fibrosis in an antibody- and T cell-independent manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, ILC2s (via IL-33), T cells (via IL-17), B cells (immunoglobulin independent), Tregs (via amphiregulin) and platelets have been suggested to directly promote HSC activation [197, 237, 242–245].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [243]
In the citing paper
“B cells also seem to promote hepatic fibrosis in the CCl4‐induced mouse model of hepatotoxicity.( 59 , 60 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [59]
In the citing paper
“Consistently, B cells have been shown to directly contribute to the evolution of inflammation and fibrosis in mouse models of NASH and hepatotoxicity.”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [59]
In the citing paper
“Intrahepatic B cells from CCl4‐treated fibrotic mice show increased activation and production of proinflammatory cytokines whereas their genetic ablation results in suppressed fibrosis.( 59 , 60 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [59]
In the citing paper
“Mice with a normal number of B cells, but impaired Ig production, are not protected from CCl4‐induced liver fibrosis, suggesting an antibody‐independent mechanism.( 59 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [59]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1968) · Medical Entomology and Zoology · Cited by 4,924
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“In a recent study (25), macrophages were shown to play distinct, Figure 2 The degree of liver fibrogenesis is proportionate to B cell numbers.”
BackgroundMice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P., Gilfillan, S., & Lantz, O. (2003) · Nature · doi:10.1038/nature01433 · Cited by 1,139 · cited 7×
“M) BALB/c (BALB) Taconic TCRδ–/– (002120) C57BL/6 (000664) Jackson Laboratory BAFF-Tg (22) C57BL/6 (000664) Jackson Laboratory mIgM-Tg (28) BALB/c (BALB) Taconic LPM2a (27) BALB/cAnNCrlBr Charles River Laboratories AReference or commercial source is provided for each strain.”
BackgroundInfluentialA T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs, G., Hentschel, J., & Wendel, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115836 · Cited by 1,074
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Alt, F. W., & Baltimore, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.13.4118 · Cited by 754
Chan, O. T. M., Hannum, L. G., Haberman, A. M., Madaio, M. P., & Shlomchik, M. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1639 · Cited by 698
Functional specialization of different hepatocyte populations
Jungermann, K., & Katz, N. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.708 · Cited by 653
Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H., & Shultz, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2049 · Cited by 583
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Crosstalk between fibroblasts and inflammatory cells
Van Linthout, S., Miteva, K., & Tschope, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 569
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
Mesenchymal stem cells: the fibroblasts' new clothes?
Haniffa, M. A., Collin, M. P., Buckley, C. D., & Dazzi, F. (2009) · Haematologica · doi:10.3324/haematol.13699 · Cited by 345
Wick, G., Grundtman, C., Mayerl, C., Wimpissinger, T.-F., Feichtinger, J., Zelger, B., Sgonc, R., & Wolfram, D. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095937 · Cited by 327
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies†
Popov, Y., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 296
B cells move to centre stage: novel opportunities for autoimmune disease treatment
Browning, J. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2085 · Cited by 279
Liver fibrosis: cellular mechanisms of progression and resolution
Henderson, N. C., & Iredale, J. P. (2007) · Clinical Science · doi:10.1042/cs20060242 · Cited by 270
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014) · Hepatology · doi:10.1002/hep.26749 · Cited by 270
“Furthermore, B cells have been shown to drive CD4(1) T-cell activation and cytokine production in the adipose tissue during obesity(34) and modulate the progression of liver injury to fibrosis.(35,36) 10 SUTTI ET AL.”
Srinivasan, M., Flynn, R., Price, A., Ranger, A., Browning, J. L., Taylor, P. A., Ritz, J., Antin, J. H., Murphy, W. J., Luznik, L., et al. (2012) · Blood · doi:10.1182/blood-2011-07-364414 · Cited by 260
Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis
Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R., & Henderson, N. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0304-x · Cited by 253
Characterization of time-related changes after experimental bile duct ligation
Georgiev, P., Jochum, W., Heinrich, S., Jang, J. H., Nocito, A., Dahm, F., & Clavien, P.-A. (2008) · British Journal of Surgery · doi:10.1002/bjs.6050 · Cited by 249
Cellular and molecular mechanisms of liver tolerance
Crispe, I. N., Giannandrea, M., Klein, I., John, B., Sampson, B., & Wuensch, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00435.x · Cited by 234
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 218
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Khomich, O., Ivanov, A. V., & Bartosch, B. (2019) · Cells · doi:10.3390/cells9010024 · Cited by 224
“survival of B cells is required for liver fibrosis in response to CCl4 treatment, while B cell deficient mice did not develop fibrosis [54,55], suggesting that besides HSCs B cells are also important drivers of fibrosis.”
BackgroundMicroanatomy of the liver immune system
Nemeth, E., Baird, A. W., & O’Farrelly, C. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0173-4 · Cited by 214
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211
“A profibrogenic role for B lymphocytes has been suggested by the resistance of B cell-deficient mice to liver fibrosis (64).”
BackgroundBarrow, F., Khan, S., Fredrickson, G., Wang, H., Dietsche, K., Parthiban, P., Robert, S., Kaiser, T., Winer, S., Herman, A., et al. (2021) · Hepatology · doi:10.1002/hep.31755 · Cited by 210
“Indeed, B cells have been shown to promote fibrosis in a model of acute liver injury.(21,39) Such pro- fibrotic function of B cells can be attributed to IL6 and instigation of T helper 1 (Th1) responses, which disrupt extracellular matrix turnover in chronic inflammation,(40) activation of hepatic stellate cells throu…”
Bosello, S., De Santis, M., Lama, G., Spanò, C., Angelucci, C., Tolusso, B., Sica, G., & Ferraccioli, G. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2965 · Cited by 199
Dual Role of CCR2 in the Constitution and the Resolution of Liver Fibrosis in Mice
Mitchell, C., Couton, D., Couty, J.-P., Anson, M., Crain, A.-M., Bizet, V., Rénia, L., Pol, S., Mallet, V., & Gilgenkrantz, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080632 · Cited by 189
Infiltrates in Protocol Biopsies from Renal Allografts
Mengel, M., Gwinner, W., Schwarz, A., Bajeski, R., Franz, I., Bröcker, V, Becker, T., Neipp, M., Klempnauer, J., Haller, H., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01635.x · Cited by 192
Hammerich, L., Bangen, J. M., Govaere, O., Zimmermann, H. W., Gassler, N., Huss, S., Liedtke, C., Prinz, I., Lira, S. A., Luedde, T., et al. (2014) · Hepatology · doi:10.1002/hep.26697 · Cited by 190
“In a model of mild chronic injury, mice deficient for the cd TCR showed similar early-stage fibrosis as WT mice.(24) In our models of advanced experimental fibrosis, we found significantly less hepatic cd T cells in Ccr6, compared to WT, mice.”
MethodLiver fibrosis: mechanisms of immune-mediated liver injury
Xu, R., Zhang, Z., & Wang, F.-S. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.53 · Cited by 183
Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies
Li, J.-T., Liao, Z.-X., Ping, J., Xu, D., & Wang, H. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2180-y · Cited by 167
Ischemia–reperfusion and immediate T cell responses
Huang, Y., Rabb, H., & Womer, K. L. (2007) · Cellular Immunology · doi:10.1016/j.cellimm.2007.03.009 · Cited by 159
Dendritic Cell Regulation of Carbon Tetrachloride–Induced Murine Liver Fibrosis Regression
Jiao, J., Sastre, D., Fiel, M. I., Lee, U. E., Ghiassi–Nejad, Z., Ginhoux, F., Vivier, E., Friedman, S. L., Merad, M., & Aloman, C. (2012) · Hepatology · doi:10.1002/hep.24621 · Cited by 154
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
François, A., Chatelus, E., Wachsmann, D., Sibilia, J., Bahram, S., Alsaleh, G., & Gottenberg, J.-E. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4352 · Cited by 149
“It was demonstrated that B cell-deficient mice treated with CC1 4 to trigger hepatic fibrosis showed a reduced collagen deposition by a mechanism dependent on antibodies but independent of T cells [4].”
Fujii, H., Cuvelier, G. D. E., She, K., Aslanian, S., Shimizu, H., Kariminia, A., Krailo, M., Chen, Z., McMaster, R., Bergman, A., et al. (2007) · Blood · doi:10.1182/blood-2007-08-106286 · Cited by 159
Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
Holt, A. P., Shepherd, E. L., Lalor, P. F., Filer, A. D., Buckley, C. D., & Adams, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.020 · Cited by 149
Calvo, S. S.-C., Bharath, L. P., Pugh, G. H., SantaCruz-Calvo, L., Lenin, R. R., Lutshumba, J., Liu, R., Bachstetter, A. D., Zhu, B., & Nikolajczyk, B. S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00575-1 · Cited by 162
Bruzzì, S., Sutti, S., Giudici, G., Burlone, M. E., Ramavath, N. N., Toscani, A., Bozzola, C., Schneider, P., Morello, E., Parola, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.015 · Cited by 139
“Recently, Zhang and co-workers have reported that feeding a high fat diet to mice leads to the liver recruitment of cells from B lineage (B220) producing pro-inflammatory cytokines [31].”
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
Novobrantseva, T. I., Borodovsky, A., Wong, J., Klebanov, B., Zafari, M., Yucius, K., Querbes, W., Ge, P., Ruda, V. M., Milstein, S., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2011.3 · Cited by 136
Self-citationThe Roles of Immune Cells in the Pathogenesis of Fibrosis
Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., & Lu, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155203 · Cited by 144
Inhibition of fibronectin deposition improves experimental liver fibrosis
Altrock, E., Sens, C., Würfel, C., Vasel, M., Kawelke, N., Dooley, S., Sottile, J., & Nakchbandi, I. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.010 · Cited by 141
CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation
Hintermann, E., Bayer, M., Pfeilschifter, J. M., Luster, A. D., & Christen, U. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.09.003 · Cited by 144
Beaven, S. W., Wroblewski, K., Wang, J., Hong, C., Bensinger, S., Tsukamoto, H., & Tontonoz, P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.053 · Cited by 131
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126
The Contribution of B Cells to Renal Interstitial Inflammation
Heller, F., Lindenmeyer, M. T., Cohen, C. D., Brandt, U., Draganovici, D., Fischereder, M., Kretzler, M., Anders, H., Sitter, T., Mosberger, I., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060554 · Cited by 136
Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M., Rodemich-Betesh, L., Krakover, J. D., Philip, R., Marrero, J. A., Dwek, R. A., & Block, T. M. (2007) · Journal of Virology · doi:10.1128/jvi.01600-07 · Cited by 137
Sun, H. Q., Zhang, J., Zhang, H., Zou, Z., Wang, F. S., & Jia, J. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01561.x · Cited by 126
Son, G., Iimuro, Y., Seki, E., Hirano, T., Kaneda, Y., & Fujimoto, J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2007 · Cited by 119
Foureau, D. M., Walling, T. L., Maddukuri, V, Anderson, W., Culbreath, K., Kleiner, D. E., Ahrens, W. A., Jacobs, C., Watkins, P. B., Fontana, R. J., et al. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12558 · Cited by 101
Hepatic Fibrosis, Stellate Cells, and Portal Hypertension
Rockey, D. C. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.017 · Cited by 112
B cells limit repair after ischemic acute kidney injury.
Jang, H., Gandolfo, M., Ko, G., Satpute, S., Racusen, L., & Rabb, H. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020182 · Cited by 109
B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
François, A., Gombault, A., Villeret, B., Alsaleh, G., Fanny, M., Gasse, P., Adam, S. M., Crestani, B., Sibilia, J., Schneider, P., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.003 · Cited by 109
Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference
Friedman, S. L., Rockey, D. C., & Bissell, M. D. (2007) · Hepatology · doi:10.1002/hep.21459 · Cited by 106
Molecular Correlates of Scarring in Kidney Transplants: The Emergence of Mast Cell Transcripts
Mengel, M., REEVE, J. P., Bunnag, S., Einecke, G., Sis, B., Mueller, T., Kalpan, B., & Halloran, P. F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02462.x · Cited by 106
Doi, H., Iyer, T. K., Carpenter, E., Li, H., Chang, K.-M., Vonderheide, R. H., & Kaplan, D. E. (2012) · Hepatology · doi:10.1002/hep.24689 · Cited by 100
Jin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2011) · Hepatology · doi:10.1002/hep.23983 · Cited by 100
Bönner, F., Borg, N., Burghoff, S., & Schrader, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034730 · Cited by 98
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. H. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 101
Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice
Huang, H., Wang, Y.-J., Zhang, Q.-Y., Liu, B., Wang, F.-Y., Li, J.-J., & Zhu, R.-Z. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6605 · Cited by 115
Liver Fibrosis Occurs Through Dysregulation of MyD88-Dependent Innate B-Cell Activity
Thapa, M., Chinnadurai, R., Velazquez, V. M., Tedesco, D., Elrod, E., Han, J., Sharma, P., Ibegbu, C., Gewirtz, A., Anania, F., et al. (2015) · Hepatology · doi:10.1002/hep.27761 · Cited by 101
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
“Markedly reduced collagen deposition and fibrosis was observed in CCl4-induced B cell-deficient mice (76).”
BackgroundReversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 98
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Rituximab efficiency in children with steroid-dependent nephrotic syndrome
Sellier‐Leclerc, A., Macher, M., Loirat, C., Guérin, V., Watier, H., Peuchmaur, M. M., Baudouin, V., & Deschênes, G. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1465-6 · Cited by 94
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2019) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 91
Bigorgne, A., Bouchet‐Delbos, L., Naveau, S., Dagher, I., Prevot, S., Durand–Gasselin, I., Couderc, J., Valet, P., Émilie, D., & Perlemuter, G. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.055 · Cited by 94
Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C†
Saadoun, D., Asselah, T., Resche‐Rigon, M., Charlotte, F., Bédossa, P., Valla, D. C., Pietté, J. C., Marcellin, P., & Cacoub, P. (2006) · Hepatology · doi:10.1002/hep.21190 · Cited by 92
Faggioli, F., Palagano, E., Di Tommaso, L., Donadon, M., Marrella, V., Recordati, C., Mantero, S., Villa, A., Vezzoni, P., & Cassani, B. (2018) · Hepatology · doi:10.1002/hep.29636 · Cited by 90
“(12) However, although it would be interesting to recapitulate our findings in other inflammation-driven models of HCC,((7,38)) different etiological settings might determine different immune responses, influencing the progression to HCC in a disease-specific context.”
BackgroundT cell-derived lymphotoxin regulates liver regeneration
Tumanov, A. V., Koroleva, E. P., Christiansen, P. A., Khan, M. A., Ruddy, M. J., Burnette, B., Papa, S., Franzoso, G., Nedospasov, S. A., Fu, Y., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.015 · Cited by 89
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Mononuclear cells in liver fibrosis
Marra, F., Aleffi, S., Galastri, S., & Provenzano, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0169-0 · Cited by 90
B cells and tertiary lymphoid organs in renal inflammation
Segerer, S., & Schlöndorff, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002734 · Cited by 85
Liu, X., Jiang, X., Liu, R., Wang, L., Qian, T., Zheng, Y., Deng, Y., Huang, E., Xu, F., Wang, J., et al. (2015) · Hepatology · doi:10.1002/hep.28001 · Cited by 80
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80
Mora, A. L., Torres-González, E., Rojas, M. M., Xu, J., Ritzenthaler, J. D., Speck, S. H., Roman, J., Brigham, K. L., & Stecenko, A. A. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1426oc · Cited by 82
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 90
Blom, K. G., Rahman Qazi, M., Noronha Matos, J. B., Nelson, B. D., DePierre, J. W., & Abedi-Valugerdi, M. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03815.x · Cited by 74
Bone Marrow-Derived B Cells Preserve Ventricular Function After Acute Myocardial Infarction
Goodchild, T. T., Robinson, K. A., Pang, W., Tondato, F. J., Cui, J., Arrington, J., Godwin, L., Ungs, M., Carlesso, N., Weich, N. S., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.08.010 · Cited by 76
B cell depletion therapy in autoimmune diseases
Sanz, I., Anolik, J. H., & Looney, R. J. (2006) · Frontiers in bioscience · doi:10.2741/2254 · Cited by 76
Immunology of the gut and liver: a love/hate relationship
Adams, D. H., Eksteen, B., & Curbishley, S. M. (2008) · Gut · doi:10.1136/gut.2007.122168 · Cited by 70
Pathogenic roles of B lymphocytes in systemic sclerosis
Yoshizaki, A. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.002 · Cited by 79
The spatial and temporal activation of macrophages during fibrosis
Behmoaras, J. V., Mulder, K., Ginhoux, F., & Petretto, E. G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01186-x · Cited by 86
Transcriptional Heterogeneity of IgM+ Cells in Rainbow Trout (Oncorhynchus mykiss) Tissues
Abós, B., Castro, R., Pignatelli, J., Luque, A., González, L., & Tafalla, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082737 · Cited by 70
Natural History of Unexplained Chronic Hepatitis After Liver Transplantation
Syn, W., Nightingale, P., Gunson, B. K., Hübscher, S. G., & Neuberger, J. (2007) · Liver Transplantation · doi:10.1002/lt.21108 · Cited by 70
B-cell targeting in chronic graft-versus-host disease
Zeiser, R., Sarantopoulos, S., & Blazar, B. R. (2018) · Blood · doi:10.1182/blood-2017-11-784017 · Cited by 68
T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
Ramadori, P., Kam, S., & Heikenwalder, M. (2022) · Hepatology · doi:10.1002/hep.32336 · Cited by 66
Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis
Gao, B., Radaeva, S., & Jeong, W.-I. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.173 · Cited by 62
Shi, J., Zhao, J., Zhang, X., Cheng, Y., Hu, J., Li, Y., Zhao, X., Shang, Q., Sun, Y., Tu, B., et al. (2017) · Scientific Reports · doi:10.1038/srep44544 · Cited by 61
Matsuda, M., & Seki, E. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111556 · Cited by 62
Feng, X., Feng, B., Zhou, J., Yang, J., Pan, Q., Yu, J., Shang, D., Li, L., & Cao, H. (2025) · Hepatology · doi:10.1097/hep.0000000000000831 · Cited by 60
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
(2024) · doi:10.1146/annurev-pharmtox-020524-012013 · Cited by 64
Metadata
- Authors
- Novobrantseva, T. I.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Novobrantseva, T. I.
- ORCID
- Novobrantseva, T. I.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-11-01
- Volume
- 115
- Issue
- 11
- Pages
- 3072-3082
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1265860
- OpenAlex
- W2065677491
- Cited by
- 277
- References
- 61
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 12 · 2023: 11 · 2022: 15 · 2021: 11 · 2020: 17 · 2019: 12 · 2018: 17 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 18 · 2013: 19 · 2012: 11
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Biogen
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, B cells, B cell-deficient mice, carbon tetrachloride, collagen deposition, B cell maturation, hepatic lymphocytes, acute liver injury
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Collagen, Liver, Liver Cirrhosis, Lymphopenia, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Spleen, B-Lymphocyte Subsets, Rats, Sprague-Dawley, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.